Learn prompt engineering with this practical cheat sheet covering frameworks, techniques, and tips to get more accurate and ...

Overwhelmed by all the automation possibilities your smart gadgets offer? You're not alone. Here are three I find useful and ...

Tech firm ‘says goodbye’ to Sora, made publicly available in 2024, just six months after its launch of a stand-alone app In an abrupt announcement on Tuesday, OpenAI said it was “saying goodbye” to ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Somewhere, deep down, I know my level-eight reaction is a mismatch to the level-three problem: I’ve fallen behind on emails, and now I seem like a total flake. My inner voice chides me, “You’re an ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Baker Hughes Company (NASDAQ:BKR) is an energy technology company that provides solutions for energy and industrial customers worldwide. Baker Hughes Company (NASDAQ:BKR) announced on February 24 that ...

The Supreme Court has taken a lot of heat in recent months over the high rate at which it has sided with the Trump Administration in interim docket cases. In his most recent post, Jack quotes James ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Grok, the AI chatbot on Elon Musk’s social media platform X, is limiting image generation and editing capabilities to paying subscribers amid a global outcry from officials and users over the tool ...